Alberto J. Montero

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (11)

Mohammadhadi Khorrami

Emory University

UNITED STATES

View details

Joohyuk Sohn

Yonsei University College of Medicine

SOUTH KOREA

View details

Anant Madabhushi

Robert Woodruff Professor

Emory University

UNITED STATES

View details

Amanda Amin

Associate Professor

University Hospital

UNITED STATES

View details

Roger Blumenthal

Johns Hopkins University School of Medicine

UNITED STATES

View details

James Martin

Assistant Professor

University Hospitals Seidman Cancer Center

UNITED STATES

View details

Vakaramoko Diaby

UNITED STATES

View details

Charu Aggarwal

University of Pennsylvania

UNITED STATES

View details

Anastasia Semykina

Deputy Dean, Research and Innovation, School of Economics, Finance and Marketing

RMIT University

AUSTRALIA

View details

Jill S Barnholtz-Sloan

Duke University School of Medicine

UNITED STATES

View details

Harikrishnan Hyma Kunhiraman

Augusta University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alberto J. Montero

Research Interests

Explore related searches

Contact this professor

Articles (13)

A novel machine learning-based cancer-specific cardiovascular disease risk score among patients with breast, colorectal, or lung cancer

A Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor–Positive Breast Cancer: The BRACELET-01/PrE0113 Study

Radiomic predicts early response to CDK4/6 inhibitors in hormone receptor positive metastatic breast cancer

Thirty-Day Unplanned Hospital Readmissions in Patients With Cancer and the Impact of Social Determinants of Health: A Machine Learning Approach

Sex differences in adults with acute myeloid leukemia and the impact of sex on overall survival

Estimating the overall survival benefit of adjuvant chemo‐endocrine therapy in women over age 50 with pT1‐2N0 early stage breast cancer and 21‐gene recurrence score ≥26: A National Cancer Database analysis

Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial

Reply to “Select cases might get a benefit from chemotherapy for Stage I pT1aN0M0 HER2+ breast cancer”

Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer

A comparison of local therapy alone with local plus systemic therapy for stage I pT1aN0M0 HER2+ breast cancer: A National Cancer Database analysis

CDK 4/6 Inhibitors: Evolution and Revolution in the Management of ER+ Metastatic Breast Cancer

Real-World Outcomes of Everolimus and Exemestane for the Treatment of Metastatic Hormone Receptor-Positive Breast Cancer in Patients Previously Treated With CDK4/6 Inhibitors

Adjuvant trastuzumab with or without chemotherapy in stage 1 pT1N0 HER2+ breast cancer: a National Cancer Database analysis

Collaborators (11)

Mohammadhadi Khorrami

Joohyuk Sohn

Anant Madabhushi

Amanda Amin

Roger Blumenthal

James Martin

Vakaramoko Diaby

Charu Aggarwal

Anastasia Semykina

Jill S Barnholtz-Sloan

Harikrishnan Hyma Kunhiraman

Make your next move.